Abstract
Recently, peroxisome proliferator−activated receptor γ (PPARγ) ligands have been reported to increase nitric oxide (NO) bioavailability in vitro but not in vivo because of the difficulty of measuring plasma NO. Here, we investigated the effects of PPARγ on plasma NO concentrations using the newly developed NO sensor in angiotensin II (Ang II)−infused rabbits. Male New Zealand rabbits were randomized for infusion with Ang II, either alone or in combination with pioglitazone (a PPARγ agonist). Plasma NO concentration was measured using the catheter-type NO sensor placed in the aorta. We then infused NG-methyl-L-arginine (L-NMMA) and acetylcholine (ACh) into the aortic arch to measure the basal and ACh-induced plasma NO concentration. Vascular nitrotyrosine levels were examined by enzyme-linked immunoassay (ELISA). Both an immunohistochemical study and Western blotting were performed to examine the PPARγ and gp91phox expression. The cotreatment with pioglitazone significantly suppressed the negative effects of Ang II, that is, the decreases in basal and ACh-induced NO production and the increase in vascular nitrotyrosine levels. Both the immunohistochemical study and Western blotting demonstrated that pioglitazone treatment enhaced PPARγ expression and greatly inhibited Ang II−induced up-regulation of gp91phox. In conclusion, the PPARγ agonist pioglitazone significantly improved NO bioavailability in Ang II−infused rabbits, most likely by attenuating nitrosative stresses. (Hypertens Res 2008; 31: 117−125)
Similar content being viewed by others
Article PDF
References
Rajagopalan S, Kurz S, Munzel T, et al : Angiotensin II−mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alternations of vasomotor tone. J Clin Invest 1996; 97: 1916–1923.
Pagano PJ, Clark JK, Cifuentes-Pagano ME, Clark SM, Callis GM, Quinn MT : Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc Natl Acad Sci U S A 1997; 94: 14483–14488.
Dinerman JL, Lowenstein CJ, Snyder SH : Molecular mechanisms of nitric oxide regulation. Circ Res 1993; 73: 217–222.
Wennmalm A, Benthin G, Petersson AS : Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood or the oxygenation of its red cell haemoglobin. Br J Pharmacol 1992; 106: 507–508.
Schechter AN, Gladwin MT : Hemoglobin and the paracrine and endocrine functions of nitric oxide. N Engl J Med 2003; 348: 1483–1485.
Stamler JS, Jia L, Eu JP, et al : Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science 1997; 276: 2034–2037.
Malinski T, Taha Z : Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor. Nature 1992; 358: 676–678.
Shibuki K : An electrochemical microprobe for detecting nitric oxide release in brain tissue. Neurosci Res 1990; 9: 69–76.
Pinsky DJ, Patton S, Mesaros S, et al : Mechanical transduction of nitric oxide synthesis in the beating heart. Circ Res 1997; 81: 372–379.
Vallance P, Patton S, Bhagat K, et al : Direct measurement of nitric oxide in human beings. Lancet 1995; 345: 153–154.
Mochizuki S, Himi N, Miyasaka T, et al : Evaluation of basic performance and applicability of a newly developed in vivo nitric oxide sensor. Physiol Meas 2002; 23: 261–268.
Mochizuki S, Miyasaka T, Goto M, et al : Measurement of acetylcholine-induced endothelium-derived nitric oxide in aorta using a newly developed catheter-type nitric oxide sensor. Biochem Biophy Res Commun 2003; 306: 505–508.
Neishi Y, Mochizuki S, Miyasaka T, et al : Evaluation of bioavailability of nitric oxide in coronary circulation by direct measurement of plasma nitric oxide concentration. Proc Natl Acad Sci U S A 2005; 102: 11456–11461.
Imanishi T, Kobayashi K, Kuroi A, Mochizuki S, Goto M, Akasaka T : Effects of angiotensin II on nitric oxide bioavailability measured using a catheter-type nitric oxide sensor. Hypertension 2006; 48: 1058–1065.
Bishop-Bailey D : Peroxisome proliferator−activated receptors in the cardiovascular system. Br J Pharmacol 2000; 129: 823–834.
Caballero AE, Saouaf R, Lim SC, et al : The effects of trogliotazone, an insulin sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial. Metabolism 2003; 52: 173–180.
Imanishi T, Jonathan M, Quoc H, Kevin D, Schwartz SM, Han DKM : Expression of cellular FLICE-inhibitory protein in human coronary arteries and in a rat vascular injury model. Am J Pathol 2000; 156: 125–137.
Ter Steege JCA, Koster-Kamphuis L, Van Straaten EA, Forget P, Buurman WA : Nitrotyrosine in plasma of celiac disease patients as detected by a new sandwich ELISA. Free Radic Biol Med 1998; 25: 953–963.
Fukushima T, Nixon JC : Analysis of reduced forms of biopterin in biological tissues and fluids. Anal Biochem 1980; 102: 176–188.
Guzik TJ, Mussa S, Gastaldi D, et al : Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 2002; 105: 1656–1662.
Sorescu D, Weiss D, Lassegue B, et al : Superoxide production and expression of Nox family proteins in human atherosclerosis. Circulation 2002; 105: 1429–1435.
Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW : Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74: 1141–1148.
Lassegue B, Sorescu D, Szocs K, et al : Novel gp91phox homologues in vascular smooth muscle cells: nox1 mediates angiotensin II−induced superoxide formation and redox-sensitive signaling pathways. Circ Res 2001; 88: 888–894.
Takeda K, Ichiki T, Tokunou T, et al : Peroxisome proliferator-activated receptor gamma activators downregulate angiotensin II type 1 receptor in vascular smooth muscle cells. Circulation 2000; 102: 1834–1839.
Sugawara A, Takeuchi K, Uruno A, et al : Transcriptional suppression of type 1 angiotensin II receptor gene expression by PPARγ in vascular smooth muscle cells. Endocrinology 2001; 142: 3125–3134.
Sugawara A, Takeuchi K, Uruno A, et al : Differential effects among thiazolidinediones on the transcription of thromboxane receptor and angiotensin II type 1 receptor gene. Hypertens Res 2001; 24: 229–233.
Gori T, Mark SS, Kelly S, Parker JD : Evidence supporting abnormalities in nitric oxide synthase function induced by nitroglycerin in humans. J Am Coll Cardiol 2001; 38: 1096–1101.
Mochizuki S, Sipkema P, Goto M, et al : Exogenous NO suppresses flow-induced endothelium-derived NO production because of depletion of tetrahydrobiopterin. Am J Physiol Heart Circ Physiol 2005; 288: H553–H558.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Imanishi, T., Kuroi, A., Ikejima, H. et al. Effects of Pioglitazone on Nitric Oxide Bioavailability Measured Using a Catheter-Type Nitric Oxide Sensor in Angiotensin II−Infusion Rabbit. Hypertens Res 31, 117–125 (2008). https://doi.org/10.1291/hypres.31.117
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1291/hypres.31.117
